Cargando…

Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro

AIM: The coronavirus disease 2019 (COVID-19) pandemic has swept the globe and no specific effective drug has been identified. Drug repurposing is a well-known method to address the crisis in a time-critical fashion. Antipsychotic drugs (APDs) have been reported to inhibit DNA replication of hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jiayu, Hou, Yajing, Ge, Shuai, Wang, Xiangjun, Wang, Jue, Hu, Tian, Lv, Yuexin, He, Huaizhen, Wang, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834886/ https://www.ncbi.nlm.nih.gov/pubmed/33310043 http://dx.doi.org/10.1016/j.lfs.2020.118889

Ejemplares similares

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Repositioning of histamine H(1) receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro
por: Wang, Xiangjun, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021)

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies
por: Zhang, Shuangzhe, et al.
Publicado: (2022)

In Vitro Evaluation of In Silico Screening Approaches in Search for Selective ACE2 Binding Chemical Probes
por: Rayevsky, Alexey V., et al.
Publicado: (2022)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zhang, Zengyuan, et al.
Publicado: (2021)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
por: Omotuyi, Olaposi, et al.
Publicado: (2023)

Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening
por: Hu, Xiaopeng, et al.
Publicado: (2022)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
por: Wu, Lili, et al.
Publicado: (2020)

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
por: Zhang, Si, et al.
Publicado: (2020)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
por: Pei, Gaofeng, et al.
Publicado: (2022)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2
por: C., Selvaa Kumar, et al.
Publicado: (2020)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
por: Guo, Yuexin, et al.
Publicado: (2021)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding
por: Miao, Lu, et al.
Publicado: (2022)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
por: Wang, Xiaoning, et al.
Publicado: (2021)

Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection
por: Wang, Jingfang, et al.
Publicado: (2020)

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
por: Tian, Fang, et al.
Publicado: (2021)

In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding
por: Bate, Neil, et al.
Publicado: (2022)

Advances in developing ACE2 derivatives against SARS-CoV-2
por: Zhang, Haoran, et al.
Publicado: (2023)

Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
por: Su, Chao, et al.
Publicado: (2022)

Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology
por: Guo, Yuexin, et al.
Publicado: (2022)

Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach
por: Lv, Yanni, et al.
Publicado: (2021)

Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2
por: Wei, Shuangshi, et al.
Publicado: (2021)

Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2
por: Tang, Lingfeng, et al.
Publicado: (2022)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Yang, Jinsung, et al.
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2
por: Benítez-Cardoza, Claudia Guadalupe, et al.
Publicado: (2021)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1703440hiub45595rgdearla4s